Arama Sonuçları Safety - Daraltılmış: Drug development.SirsiDynix Enterprisehttps://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dSafety$0026qf$003dSUBJECT$002509Subject$002509Drug$002bdevelopment.$002509Drug$002bdevelopment.$0026ic$003dtrue$0026ps$003d300?2025-12-27T18:01:00ZSafety pharmacology in pharmaceutical development : approval and post marketing surveillanceent://SD_ILS/0/SD_ILS:5467782025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Gad, Shayne C., 1948, author. Gad, Shayne C., 1948- Safety pharmacology in pharmaceutical development and approval.<br/>Yer Numarası RM301.25 .G33 2012<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439845684">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Drug development principles, methodology and emerging challengesent://SD_ILS/0/SD_ILS:2810632025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Rossi, Marco. Bertone, Santina.<br/>Yer Numarası ONLINE<br/>Elektronik Erişim EBSCOhost <a href="http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=564963">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=564963</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Handbook of Bioethical Decisions. Volume I Decisions at the Benchent://SD_ILS/0/SD_ILS:5278542025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Valdés, Erick. editor. Lecaros, Juan Alberto. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-29451-8">https://doi.org/10.1007/978-3-031-29451-8</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Pharmaceutical Calibration, Validation and Qualification: A Comprehensive Approachent://SD_ILS/0/SD_ILS:5271512025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Shukla, Shiv Shankar. author. Pandey, Ravindra Kumar. author. Gidwani, Beena. author. Kalyani, Gunjan. author. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-981-19-9002-1">https://doi.org/10.1007/978-981-19-9002-1</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Data Monitoring Committees (DMCs) Past, Present, and Futureent://SD_ILS/0/SD_ILS:5278312025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Rawat, Nand Kishore. editor. Kerr, David. editor. SpringerLink (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim <a href="https://doi.org/10.1007/978-3-031-28760-2">https://doi.org/10.1007/978-3-031-28760-2</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Controversial statistical issues in clinical trialsent://SD_ILS/0/SD_ILS:5475542025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Chow, Shein-Chung, 1955, author.<br/>Yer Numarası RM301.27 .C475 2011<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439849620">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical drug developmentent://SD_ILS/0/SD_ILS:5430282025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Rogge, Mark C. Taft, David R.<br/>Yer Numarası RM301.25 .P745 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420084733">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Active pharmaceutical ingredients : development, manufacturing, and regulationent://SD_ILS/0/SD_ILS:5401132025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Nusim, Stanley.<br/>Yer Numarası RM301.25 .A28 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439803394">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Biochips as pathways to drug discoveryent://SD_ILS/0/SD_ILS:5388322025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Carmen, Andrew. Hardiman, Gary, 1966-<br/>Yer Numarası R857 .B5 B54 2007<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420015607">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>In vivo MR techniques in drug discovery and developmentent://SD_ILS/0/SD_ILS:5398912025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Beckmann, Nicolau.<br/>Yer Numarası RM301.25 .I5 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420004526">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Dose Optimization in Drug Developmentent://SD_ILS/0/SD_ILS:5469742025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Krishna, Rajesh, editor. Taylor and Francis.<br/>Yer Numarası RM301.8 .D67 2006<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429136016">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical Drug Developmentent://SD_ILS/0/SD_ILS:5401032025-12-27T18:01:00Z2025-12-27T18:01:00ZYazar Rogge, Mark C., editor. Taft, David R., editor. Taylor and Francis.<br/>Yer Numarası RM301.25 .P745 2005<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429163210">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>